Clinical Trial Update: Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenalidomide in older patients with chronic lymphocytic leukemia. The study results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Leukemia

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2017-05-18